| Zinc-dependent regulation of ZEB1 and YAP1 coactivation promotes epithelial-mesenchymal transition plasticity and metastasis in pancreatic cancer M Liu, Y Zhang, J Yang, H Zhan, Z Zhou, Y Jiang, X Shi, X Fan, J Zhang, ... Gastroenterology 160 (5), 1771-1783. e1, 2021 | 108 | 2021 |
| ZIP4 increases expression of transcription factor ZEB1 to promote integrin α3β1 signaling and inhibit expression of the gemcitabine transporter ENT1 in pancreatic cancer cells M Liu, Y Zhang, J Yang, X Cui, Z Zhou, H Zhan, K Ding, X Tian, Z Yang, ... Gastroenterology 158 (3), 679-692. e1, 2020 | 100 | 2020 |
| A CXC chemokine receptor type 2–dominated cross-talk between tumor cells and macrophages drives gastric cancer metastasis Z Zhou, G Xia, Z Xiang, M Liu, Z Wei, J Yan, W Chen, J Zhu, N Awasthi, ... Clinical Cancer Research 25 (11), 3317-3328, 2019 | 92 | 2019 |
| A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis Z Xiang, ZJ Zhou, GK Xia, XH Zhang, ZW Wei, JT Zhu, J Yu, W Chen, ... Oncogene 36 (36), 5122-5133, 2017 | 86 | 2017 |
| ZIP4 promotes pancreatic cancer progression by repressing ZO-1 and claudin-1 through a ZEB1-dependent transcriptional mechanism M Liu, J Yang, Y Zhang, Z Zhou, X Cui, L Zhang, KM Fung, W Zheng, ... Clinical Cancer Research 24 (13), 3186-3196, 2018 | 80 | 2018 |
| METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability H Li, C Wang, L Lan, L Yan, W Li, I Evans, EJ Ruiz, Q Su, G Zhao, W Wu, ... Cellular and Molecular Life Sciences 79 (3), 135, 2022 | 58 | 2022 |
| Targeted therapies for cancer Z Zhou, M Li BMC Medicine, 2022 | 57 | 2022 |
| Circular RNA ANAPC7 inhibits tumor growth and muscle wasting via PHLPP2–AKT–TGF-β signaling Axis in pancreatic cancer X Shi, J Yang, M Liu, Y Zhang, Z Zhou, W Luo, KM Fung, C Xu, MS Bronze, ... Gastroenterology 162 (7), 2004-2017. e2, 2022 | 54 | 2022 |
| Dexamethasone suppresses immune evasion by inducing GR/STAT3 mediated downregulation of PD-L1 and IDO1 pathways Z Xiang, Z Zhou, S Song, J Li, J Ji, R Yan, J Wang, W Cai, W Hu, L Zang, ... Oncogene 40 (31), 5002-5012, 2021 | 51 | 2021 |
| Evaluation of BRCA1 and BRCA2 as indicators of response to immune checkpoint inhibitors Z Zhou, M Li JAMA Network Open 4 (5), e217728-e217728, 2021 | 48 | 2021 |
| FYN promotes gastric cancer metastasis by activating STAT3-mediated epithelial-mesenchymal transition J Yu, ZJ Zhou, ZW Wei, J Wu, J OuYang, WB Huang, YL He, CH Zhang Translational oncology 13 (11), 100841, 2020 | 38 | 2020 |
| An integrated model of N6-methyladenosine regulators to predict tumor aggressiveness and immune evasion in pancreatic cancer Z Zhou, J Zhang, C Xu, J Yang, Y Zhang, M Liu, X Shi, X Li, H Zhan, ... EBioMedicine 65, 2021 | 37 | 2021 |
| MTAP Deficiency–Induced Metabolic Reprogramming Creates a Vulnerability to Cotargeting De Novo Purine Synthesis and Glycolysis in Pancreatic Cancer Q Hu, Y Qin, S Ji, X Shi, W Dai, G Fan, S Li, W Xu, W Liu, M Liu, Z Zhang, ... Cancer research 81 (19), 4964-4980, 2021 | 22 | 2021 |
| Identification of stemness characteristics associated with the immune microenvironment and prognosis in gastric cancer D Mao, Z Zhou, S Song, D Li, Y He, Z Wei, C Zhang Frontiers in oncology 11, 626961, 2021 | 20 | 2021 |
| Hypoxia activated HGF expression in pancreatic stellate cells confers resistance of pancreatic cancer cells to EGFR inhibition X Shi, M Wang, Y Zhang, X Guo, M Liu, Z Zhou, Y Zhao, R He, Y Gao, ... EBioMedicine 86, 2022 | 19 | 2022 |
| ZIP4 promotes non-small cell lung cancer metastasis by activating snail-N-cadherin signaling axis Y Jiang, H Zhan, Y Zhang, J Yang, M Liu, C Xu, X Fan, J Zhang, Z Zhou, ... Cancer letters 521, 71-81, 2021 | 19 | 2021 |
| Acetyl-coenzyme A synthetase 2 potentiates macropinocytosis and muscle wasting through metabolic reprogramming in pancreatic cancer Z Zhou, Y Ren, J Yang, M Liu, X Shi, W Luo, KM Fung, C Xu, MS Bronze, ... Gastroenterology 163 (5), 1281-1293. e1, 2022 | 15 | 2022 |
| Association of body composition with risk of overall and site‐specific cancers: a population‐based prospective cohort study Q He, B Xia, A Liu, M Li, Z Zhou, EC Cheung, ZC Kuo, B Wang, F Li, ... International journal of cancer 149 (7), 1435-1447, 2021 | 15 | 2021 |
| PARP1 inhibitor combined with oxaliplatin efficiently suppresses oxaliplatin resistance in gastric cancer-derived organoids via homologous recombination and the base excision … H Li, C Wang, L Lan, W Wu, I Evans, EJ Ruiz, L Yan, Z Zhou, JM Oliveira, ... Frontiers in cell and developmental biology 9, 719192, 2021 | 12 | 2021 |
| CHD4 promotes acquired chemoresistance and tumor progression by activating the MEK/ERK axis J Wu, Z Zhou, J Li, H Liu, H Zhang, J Zhang, W Huang, Y He, S Zhu, ... Drug Resistance Updates 66, 100913, 2023 | 9 | 2023 |
